PDL BioPharma Appoints Chief Accounting Officer

PDL BioPharma, which manages a portfolio of patents and royalty assets, has appointed Steffen Pietzke as controller and chief accounting officer. Pietzke joins PDL from Ernst & Young, where he held the position of senior manager since 2013. Details inside.

THIS IS MEMBERS-ONLY CONTENT

SINGLE MEMBERSHIP                                             CORPORATE MEMBERSHIP

You are not logged in and do not have access to members-only content.

If you are already a registered user or a member, SIGN IN now.